The changing face of mantle cell lymphoma.

被引：0
|
作者：
Goepel, JR
Lorigan, PC
Vandenberghe, EA
Allen, JE
Hammond, DW
Hancock, BW
机构：
[1] Royal Hallamshire Hosp, Dept Haematol, Sheffield S10 2JF, S Yorkshire, England
[2] Royal Hallamshire Hosp, Inst Canc Studies, Sheffield S10 2JF, S Yorkshire, England
[3] Royal Hallamshire Hosp, Dept Pathol, Sheffield S10 2JF, S Yorkshire, England
[4] Weston Pk Hosp, Yorkshire Canc Res Dept Clin Oncol, Sheffield, S Yorkshire, England
来源：
BRITISH JOURNAL OF CANCER | 1998年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
006
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [41] Cytarabine and hematopoietic cell transplantation for mantle cell lymphoma. Analysis of 20 patients
    Campbell, James
    Hurtado, Sebastian
    Kutz, Consuelo
    Soto, Katherine
    Ernst, Daniel
    REVISTA MEDICA DE CHILE, 2019, 147 (01) : 9 - 17
  • [42] Fludarabine, mitoxantrone and rituxan: An effective regimen for the treatment of mantle cell lymphoma.
    Levine, AM
    Espina, BM
    Mohrbacher, A
    Buchanan, LH
    Berman, N
    Mark, L
    Khan, AU
    Tulpule, A
    Douer, D
    BLOOD, 2002, 100 (11) : 361A - 362A
  • [43] DNA repair abnormalities leading to radiation sensitivity in mantle cell lymphoma.
    Mkacher, R
    Farace, F
    Ribrag, V
    Dossou, J
    Bernheim, A
    Parmentier, C
    Turhan, AG
    BLOOD, 2000, 96 (11) : 333A - 333A
  • [44] Integrated CGH- and epression array profiling of mantle cell lymphoma.
    Schraders, Margit
    Jares, Pedro
    Bea, Silvia
    Schoenmakers, Eric F. P. M.
    Van Krieken, Joannes H. J. M.
    Campo, Elias
    Groenen, Patricia J. T. A.
    BLOOD, 2006, 108 (11) : 637A - 638A
  • [45] Prognostic value of CD71 expression in mantle cell lymphoma.
    Lanson, B
    Drenou, B
    Gueret, P
    Amiot, L
    Bernard, M
    Dauriac, C
    LePrise, PY
    Fauchet, R
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 401 - 401
  • [46] Deferred treatment as a viable option for selected patients with mantle cell lymphoma.
    Calzada, Oscar
    Switchenko, Jeffrey M.
    Maly, Joseph J.
    Blum, Kristie A.
    Grover, Natalie Sophia
    Mathews, Stephanie
    Park, Steven I.
    Gordon, Max J.
    Danilov, Alexey Valeryevich
    Flowers, Christopher
    Cohen, Jonathon Brett
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Synergistic cytotoxic effects of selinexor and chloroquine phosphate in mantle cell lymphoma.
    Zhang, Yongyi
    Zhang, Kejie
    Chen, Yuhan
    Zhang, Daibo
    Yao, Qin
    Zhuo, Huiqin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Efficiency of rituximab plus DRAP in the treatment of patients with mantle cell lymphoma.
    Jaccard, A
    Touati, M
    Gachard, N
    Chaury, MP
    Remenieras, L
    Turlure, P
    Bordessoule, D
    BLOOD, 2002, 100 (11) : 315B - 315B
  • [49] Circulating tumor DNA to predict timing of relapse in mantle cell lymphoma.
    Roschewski, Mark J.
    Melani, Christopher Joseph
    Pittaluga, Stefania
    Dunleavy, Kieron
    Saba, Nakhle S.
    Grant, Cliona
    Aaron, Joan
    Jacob, Allison
    Yusko, Erik
    Steinberg, Seth M.
    Jaffe, Elaine S.
    Wiestner, Adrian
    Wilson, Wyndham Hopkins
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Biased VH gene usage and somatic hypermutation in mantle cell lymphoma.
    Thorselius, M
    Walsh, S
    Eriksson, I
    Thunberg, U
    Johnson, A
    Backlin, C
    Enblad, G
    Sundstrom, C
    Roos, G
    Rosenquist, R
    BLOOD, 2001, 98 (11) : 331A - 331A
12345